Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...
Global solar growth is flattening in major markets as oversupply from China and India drives prices down and shifts competition from sheer volume to execution, policy alignment, and system integration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback